Axsome Therapeutics, Inc. (0HKF.L)

USD 94.11

(0.14%)

Eps Summary of Axsome Therapeutics, Inc.

  • Axsome Therapeutics, Inc.'s latest annual eps in 2023 was -5.27 USD , down -8.44% from previous year.
  • Axsome Therapeutics, Inc.'s latest quarterly eps in 2024 Q2 was -1.67 USD , down -15.97% from previous quarter.
  • Axsome Therapeutics, Inc. reported an annual eps of -4.86 USD in 2022, down -35.38% from previous year.
  • Axsome Therapeutics, Inc. reported an annual eps of -3.59 USD in 2021, down -26.86% from previous year.
  • Axsome Therapeutics, Inc. reported a quarterly eps of -1.67 USD for 2024 Q2, down -15.97% from previous quarter.
  • Axsome Therapeutics, Inc. reported a quarterly eps of -1.54 USD for 2023 Q2, down -492.31% from previous quarter.

Annual Eps Chart of Axsome Therapeutics, Inc. (2023 - 2013)

Historical Annual Eps of Axsome Therapeutics, Inc. (2023 - 2013)

Year Eps Eps Growth
2023 -5.27 USD -8.44%
2022 -4.86 USD -35.38%
2021 -3.59 USD -26.86%
2020 -2.83 USD -38.05%
2019 -2.05 USD -78.26%
2018 -1.15 USD 9.45%
2017 -1.27 USD 10.56%
2016 -1.42 USD -61.36%
2015 -0.88 USD -87.23%
2014 -0.47 USD -176.47%
2013 -0.17 USD 0.0%

Peer Eps Comparison of Axsome Therapeutics, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD -160.891%
Dynavax Technologies Corporation -0.05 USD -10525.0%
Supernus Pharmaceuticals, Inc. 0.02 USD 21967.22%
Perrigo Company plc -0.09 USD -5512.354%
Illumina, Inc. -7.35 USD 28.299%
Thermo Fisher Scientific Inc. 15.53 USD 133.934%
Iovance Biotherapeutics, Inc. -1.89 USD -178.836%
Walgreens Boots Alliance, Inc. -10.01 USD 47.353%
IQVIA Holdings Inc. 7.39 USD 171.313%
Heron Therapeutics, Inc. -0.80 USD -558.75%
Regeneron Pharmaceuticals, Inc. 37.05 USD 114.224%
Unity Biotechnology, Inc. -2.70 USD -95.185%
Waters Corporation 10.87 USD 148.482%
Biogen Inc. 8.02 USD 165.711%
Sangamo Therapeutics, Inc. -1.48 USD -256.081%
Evolus, Inc. -1.08 USD -387.963%
Adicet Bio, Inc. -3.31 USD -59.215%
Cara Therapeutics, Inc. -2.19 USD -140.639%
bluebird bio, Inc. -1.93 USD -173.057%
Esperion Therapeutics, Inc. -2.03 USD -159.606%
FibroGen, Inc. -2.92 USD -80.479%
Agilent Technologies, Inc. 4.22 USD 224.882%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 48.885%
Homology Medicines, Inc. -7.41 USD 28.88%
Geron Corporation -0.32 USD -1546.875%
Alnylam Pharmaceuticals, Inc. -3.52 USD -49.716%
Amicus Therapeutics, Inc. -0.51 USD -933.333%
Myriad Genetics, Inc. -1.39 USD -279.137%
Viking Therapeutics, Inc. -0.91 USD -479.121%
Intellia Therapeutics, Inc. -5.42 USD 2.768%
Zoetis Inc. 5.08 USD 203.74%
Abeona Therapeutics Inc. -2.53 USD -108.3%
Mettler-Toledo International Inc. 36.10 USD 114.598%
BioMarin Pharmaceutical Inc. 0.89 USD 692.135%
Vertex Pharmaceuticals Incorporated 14.05 USD 137.509%
Kala Pharmaceuticals, Inc. -17.35 USD 69.625%
Ionis Pharmaceuticals, Inc. -2.56 USD -105.859%
Atara Biotherapeutics, Inc. -65.18 USD 91.915%
Verastem, Inc. -3.96 USD -33.081%
Nektar Therapeutics -1.45 USD -263.448%
Aclaris Therapeutics, Inc. -1.27 USD -314.961%
Sarepta Therapeutics, Inc. -5.80 USD 9.138%
OPKO Health, Inc. -0.25 USD -2008.0%
Exelixis, Inc. 0.65 USD 910.769%
Neurocrine Biosciences, Inc. 2.56 USD 305.859%
Corcept Therapeutics Incorporated 1.02 USD 616.667%
Anavex Life Sciences Corp. -0.60 USD -778.333%
uniQure N.V. -6.47 USD 18.547%
Imunon, Inc. -2.16 USD -143.981%
Blueprint Medicines Corporation -8.37 USD 37.037%
Insmed Incorporated -5.34 USD 1.311%
Halozyme Therapeutics, Inc. 2.13 USD 347.418%
Agios Pharmaceuticals, Inc. -6.33 USD 16.746%
TG Therapeutics, Inc. 0.09 USD 6001.456%
Incyte Corporation 2.67 USD 297.378%
Emergent BioSolutions Inc. -14.85 USD 64.512%